The FDA approved a wearable tumor-treating fields (TTFields) device (Optune Lua) for concurrent use with a PD-1/PD-L1 ...

Stereotactic body radiotherapy was associated with significantly better urinary continence and fewer sexual issues at 2 years ...

Men with localized prostate cancer were randomly assigned to receive either SBRT or control radiotherapy in a phase 3 trial.

Behind breast cancer, prostate cancer is the second most common cancer in the United States. Since its opening in 2012, the ...

New research provides scientific evidence that a healthy diet may reduce the chance of low risk prostate cancer progressing to a more aggressive state in men undergoing active surveillance -- a ...

Men with prostate cancer diagnosed at an early stage may be able to slow the progression of their disease by adopting a ...

In a study believed to be the first of its kind published, a research team led by Johns Hopkins Medicine provides scientific ...

Prostate cancer is the second leading cause of cancer death among American men. A recent study, conducted by researchers from ...

With approaches like high intensity focused ultrasound, patients with prostate cancer may experience lower rates of urinary ...

At the moment, patients must request a blood test from their doctor, but Prostate Cancer UK is calling for change.

Exclusive: “Unfortunately, most of the genetic research that had been published focused only on people of white, European ...

Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET ...